Trial · NCT05283304
Adverse events56
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 56
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Adverse Drug Reaction | General disorders | Injectable Buprenorphine (BUP-inj) | 1 | 5 | 1 |
| other | Adverse Drug Reaction | General disorders | Injectable Placebo (PBO-inj) | 0 | 13 | 0 |
| other | Mental Status Changes | Psychiatric disorders | Injectable Buprenorphine (BUP-inj) | 1 | 5 | 1 |
| other | Mental Status Changes | Psychiatric disorders | Injectable Placebo (PBO-inj) | 0 | 13 | 0 |
| other | Constipation | Gastrointestinal disorders | Injectable Buprenorphine (BUP-inj) | 1 | 5 | 1 |
| other | Constipation | Gastrointestinal disorders | Injectable Placebo (PBO-inj) | 3 | 13 | 3 |
| other | Dizziness | Nervous system disorders | Injectable Buprenorphine (BUP-inj) | 0 | 5 | 0 |
| other | Dizziness | Nervous system disorders | Injectable Placebo (PBO-inj) | 4 | 13 | 4 |
| other | Hyperhidrosis | Skin and subcutaneous tissue disorders | Injectable Buprenorphine (BUP-inj) | 1 | 5 | 1 |
| other | Hyperhidrosis | Skin and subcutaneous tissue disorders | Injectable Placebo (PBO-inj) | 4 | 13 | 4 |
| other | Lethargy | Nervous system disorders | Injectable Buprenorphine (BUP-inj) | 0 | 5 | 0 |
| other | Lethargy | Nervous system disorders | Injectable Placebo (PBO-inj) | 1 | 13 | 1 |
| other | Nausea | Gastrointestinal disorders | Injectable Buprenorphine (BUP-inj) | 3 | 5 | 4 |
| other | Nausea | Gastrointestinal disorders | Injectable Placebo (PBO-inj) | 4 | 13 | 4 |
| other | Pain | General disorders | Injectable Buprenorphine (BUP-inj) | 0 | 5 | 0 |
| other | Pain | General disorders | Injectable Placebo (PBO-inj) | 1 | 13 | 1 |
| other | Headache | Nervous system disorders | Injectable Buprenorphine (BUP-inj) | 0 | 5 | 0 |
| other | Headache | Nervous system disorders | Injectable Placebo (PBO-inj) | 2 | 13 | 2 |
| other | Electrocardiogram ST Segment elevation | Investigations | Injectable Buprenorphine (BUP-inj) | 0 | 5 | 0 |
| other | Electrocardiogram ST Segment elevation | Investigations | Injectable Placebo (PBO-inj) | 1 | 13 | 1 |
Source ClinicalTrials.govtrials-2026-11-12-0.4.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNone stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT05283304/events